What is it about?
This article aims to discuss the pathogenesis of infections due to enterococci harboring the vanB operon (vanB VRE) and their therapeutic, state-of-the-art, and future treatment options and provide a comprehensive and easy-to-use review for clinical purposes
Featured Image
Photo by CDC on Unsplash
Why is it important?
It can guide clinicians for a targeted therapy against vanB VRE
Read the Original
This page is a summary of: Therapeutic Options for Infections Due to vanB Genotype Vancomycin-Resistant Enterococci, Microbial Drug Resistance, April 2021, Mary Ann Liebert Inc,
DOI: 10.1089/mdr.2020.0171.
You can read the full text:
Contributors
The following have contributed to this page
